Evidence map›Paper›PMID 15139290›Full record

ArticleNeurochemical research2004

Activation of cell cycle regulatory proteins in the apoptosis of terminally differentiated oligodendrocytes.

M Strazza, A Luddi, A Brogi, M Carbone, M Riccio, S Santi, M Melli, E Costantino-Ceccarini

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Neurochemical research, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Cell cycle activation and CNS injury.Neurotoxicity research · 2009
    Article
  3. Multifunctional drug treatment in neurotrauma.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2009
    Review
  4. Article
  5. Role of cell cycle proteins in CNS injury.Neurochemical research · 2007
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

M StrazzaIstituto di Fisiologia Clinica, Sez di Siena, 53100 Siena, Italy.
A Luddi
A Brogi
M Carbone
M Riccio
S Santi
M Melli
E Costantino-Ceccarini
Istituto di Fisiologia Clinica · ITUniversity of Bologna · IT

Funding

Telethon A.139
6 · The paper itself

Abstract

There is increasing evidence that proteins normally involved in the cell cycle play a role in the regulation of neuronal apoptotic death following various insults. However, it is not clear if the same mechanisms regulate cell death of oligodendrocytes as well. In this study, we investigated the mechanism of ceramide-induced apoptosis in primary rat oligodendrocytes. We show that ceramide treatment initiates a cascade of biochemical events involving cell cycle regulatory proteins. Although at the time of induction of cell death the oligodendrocytes are postmitotic, activation of c-myc and translocation of Cdc25A into the nucleus can be demonstrated. Of particular interest are the findings of the up-regulation of PCNA and down-regulation of p21WAF1/CIP1 protein, an inhibitor of cell-cycle progression. The current results show that activation of regulatory cell-cycle proteins at the oligodendrocytes G1-S checkpoint may constitute a crucial step of the death pathway of oligodendrocytes.

Indexed as

AnimalsApoptosiscdc25 PhosphatasesCell Cycle ProteinsCell DifferentiationCells, CulturedCeramidesOligodendrogliaProliferating Cell Nuclear AntigenProto-Oncogene Proteins c-mycRatsRats, Sprague-DawleyCdc25a protein, ratcdc25 PhosphatasesCell Cycle ProteinsCeramidesProliferating Cell Nuclear AntigenProto-Oncogene Proteins c-myc

Identifiers

PMID15139290
OpenAlexW1978257716

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.